Levels of carcinoembryonic antigen and CA 19-9 in the sera and peritoneal washing of patients undergoing surgical treatment for gastric carcinoma

Arquivos de Gastroenterologia

Volumn 45, Issue 3, 2008, Pages 219-224

  Crepaldi Filho, René ^a   Palma, Rogério Tadeu ^a   Giusti, Marcelo Franchini ^a   Bueno, Marina De Assis Galvão ^a   Da Silva, Paulo Sérgio Lucas ^a   Waisberg, Jaques ^a,b  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b Bairro Jardim   (Brazil)

Author keywords

CA 19 9 antigen; Carcinoembryonic antigen; Carcinoma; Peritoneal lavage; Stomach neoplasms

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; MALE; PERITONEAL CAVITY; PERITONEUM LAVAGE; STOMACH CARCINOMA; STOMACH LAVAGE; STOMACH WALL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL LAVAGE; PREDICTIVE VALUE OF TESTS; STOMACH NEOPLASMS;

EID: 55249094331     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032008000300010     Document Type: Article

References (30)

1. Abe S, Yoshimura H, Tabara H, Tachibana M, Monden N, Nakamura T, Nagaoka S. Curative resection of gastric cancer: limitation of peritoneal lavage cytology predicting the outcome. J Surg Oncol. 1995;59:226-9.
2. Baba H, Korenaga D, Okamura T, Saito A, Sugimachi K. Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses. Arch Surg. 1989;124:1061-4.
3. Benevolo M, Mottolese M, Cosimelli M, Tedesco M, Giannarelli D, Vasselli S, Carlini M, Garofalo A, Natali PG. Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol. 1998;16:3406-11
4. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med. 1986;104:66-73.
5. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 1965;121:439-62.
6. Guadagni S, Catarci M, Kinoshita T, Valenti M, De Benardinis G, Carboni M. Causes of death and recurrence after surgery for early gastric cancer. World J Surg. 1997;21:434-9.
7. Gupta MK, Arciaga R, Bocci L, Tubbs R, Raymond T, Bukowski R, Deodhar SD. Measurement of a monoclonal-antibody-defined antigen (CA 19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen. Cancer. 1985;56:277-83.
8. Haglund C, Roberts PJ, Jalanko H, Kuusela P. Tumor markers CA 19-9 and CA 50 in digestive tract malignancies. Scand J Gastroenterol. 1992;27:169-74.
9. Irinoda T, Terashima M, Takagane A, Sasaki N, Abe K, Araya M, Nishizuka S, Yonezawa H, Nakaya T, Shimooki O, Oyama K, Ikeda K, Saito K. Carcinoembryonic antigen level in peritoneal washing is a prognostic factor in patients with gastric cancer. Oncol Rep. 1998;5:661-6.
10. Ito S, Nakanishi H, Kodera Y, Mochizuki Y, Tatematsu M, Yamamura Y. Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients. Br J Cancer. 2005;93:986-92.
11. Joypaul B, Browning M, Newman E, Byrne D, Cuschieri A. Comparison of serum CA 72-4 and CA 19-9 levels in gastric cancer patients and correlation with recurrence. Am J Surg. 1995;169:595-9.
12. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, Morimoto T, Kato T, Kito T. The prognostic value of preoperative serum levels of CEA and CA 19-9 in patients with gastric cancer. Am J Gastroenterol. 1996;91:49-53.
13. Koga T, Kano T, Souda K, Oka N, Inokuchi K. The clinical usefulness of preoperative CEA determination in gastric cancer. Jpn J Surg. 1987;17:342-7.
14. Lourenço LG, Hamada GS. Gastric cancer in Brazil. Gastric cancer. 2001;4:103-5.
15. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000;87:353-7.
16. Magnani JL, Steplewski Z, Koprowski H, Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 1983;43:5489-92.
17. Mandorwski S, Lourenço LG, Forones NM. CA 72-4 e CEA no soro e no lavado peritoneal de doentes com câncer gástrico. Arq Gastroenterol. 2002;39:17-21.
18. Mattar R, Andrade CRA, Mastrantonio F, Gama-Rodrigues JJ, Laudanna AA. Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Rev Hosp Clin Fac Med S Paulo. 2002;57:89-92.
19. Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, Yakeishi Y, Matsukuma A, Enjoji M. Pathology and prognosis of gastric carcinoma; findings in 10.000 patients who underwent primary gastrectomy. Cancer. 1992;70:1030-7.
20. Nakane Y, Okamura S, Akehira K, Boku T, Okusa T, Tanaka K, Hioki K. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients. Cancer. 1994;73:2703-8.
21. Pectasides D, Mylonakis A, Kostopoulou M, Papadopoulou M, Triantafillis D, Varthalitis J, Dimitriades M, Athanassiou A. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol. 1997;20:348-53.
22. Ribeiro U Jr, Safatle-Ribeiro AV, Zilberstein B, Mucerino D, Yagi OK, Bresciani CC, Jacob C, Iryia K, Gama-Rodrigues J. Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection? J Gastrointest Surg. 2006;10:170-7.
23. Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer. 1993;72:3174-8.
24. Souza Jr OG, Souza EMN, Feio FMS. Correlação da dosagem sérica do CA 19-9 em pacientes com adenocarcinoma gástrico. Rev Para Med. 1999;13:29-33.
25. Tachibana M, Takemoto Y, Nakashima Y, Kinugasa S, Kotoh T, Dhar DK, Kolmo H, Nagasue N. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer. J Am Coll Surg. 1998;187:64-8.
26. Tomasich FDS, Augusto VC, Luz MA, Dias LAN, Kato M. Correlaç ão entre os marcadores tumorais CEA e CA 19-9 e a profundidade de invasão no câncer gástrico. Rev Bras Cancerol. 2002;48:57-62.
27. Victorzon M, Haglund C, Lundin J, Roberts PJ. A prognostic value of CA 19-9 but not of CEA in patients with gastric cancer. Eur J Surg Oncol. 1995;21:379-84.
28. Wobbes T, Thomas CMG, Segers MFG, Nagengast FM. Evaluation of seven tumor markers (CA 50, CA 19-9 TruQuant, CA 19-9, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma. Cancer. 1992;69:2036-41.
29. Yamamoto M, Baba H, Kakeji Y, Endo K, Ikeda Y, Toh Y, Kohnoe S, Okamura T, Maeharo Y. Prognostic significance of tumor markers in peritoneal lavage in advanced gastric cancer. Oncology. 2004;67:19-26.
30. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236-42.